Long-term outcomes and prognostic factors of complications in Takayasu arteritis: A multicenter study of 318 patients

Circulation

Volumn 136, Issue 12, 2017, Pages 1114-1122

  Comarmond, Cloé ^a,b,c,d   Biard, Lucie ^b,e   Lambert, Marc ^f   Mekinian, Arsène ^g   Ferfar, Yasmina ^d   Kahn, Jean Emmanuel ^h   Benhamou, Ygal ⁱ   Chiche, Laurent ^d   Koskas, Fabien ^d   Cluzel, Philippe ^a,b,c,d   Hachulla, Eric ^f   Messas, Emmanuel ^j   Resche Rigon, Matthieu ^b,e   Cacoub, Patrice ^c   Mirault, Tristan ^j   Saadoun, David ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIV LILLE   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h FOCH HOSPITAL   (France)

ⁱ ROUEN UNIVERSITY HOSPITAL   (France)

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

Outcome; Prognosis; Relapse; Takayasu arteritis; Vasculitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLATE MOFETIL;

ADULT; AORTIC ARCH SYNDROME; ARTICLE; CAROTID ARTERY DISEASE; CAROTIDYNIA; DISEASE COURSE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RETINOPATHY; RETROSPECTIVE STUDY; THORACIC AORTA; VASCULAR DISEASE; ADOLESCENT; AGED; CARDIOVASCULAR DISEASE; CHILD; COMPLICATION; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TAKAYASU ARTERITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AORTA, THORACIC; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHILD; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TAKAYASU ARTERITIS; YOUNG ADULT;

EID: 85024476496     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.027094     Document Type: Article

References (25)

1. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS. Takayasu arteritis. Ann Intern Med. 1994;120:919-929.
2. Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, Ishibashi- Ueda H, Kobayashi J, Yagihara T, Kitamura S. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation. 2008;118:2738-2747. doi: 10.1161/CIRCULATIONAHA.107.759589.
3. Watts R, Al-Taiar A, Mooney J, Scott D, Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009;48:1008-1011. doi: 10.1093/rheumatology/kep153.
4. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation. 1978;57:27-35.
5. Strachan RW. The National History of Takayasu's Arteriopathy. Q J Med. 1964;33:57-69.
6. Ishikawa K. Patterns of symptoms and prognosis in occlusive thromboaortopathy (Takayasu's disease). J Am Coll Cardiol. 1986;8:1041-1046.
7. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease: clinical and statistical analyses of related prognostic factors. Circulation. 1994;90:1855-1860.
8. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation. 1989;80:429-437.
9. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(Suppl):S155-S163.
10. Hong S, Bae SH, Ahn SM, Lim DH, Kim YG, Lee CK, Yoo B. Outcome of takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation. J Rheumatol. 2015;42:489-494. doi: 10.3899/jrheum.140981.
11. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G; Itaka Study Group. Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum. 2005;53:100-107. doi: 10.1002/art.20922.
12. Waern AU, Andersson P, Hemmingsson A. Takayasu's arteritis: a hospitalregion based study on occurrence, treatment and prognosis. Angiology. 1983;34:311-320. doi: 10.1177/000331978303400504.
13. Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Costedoat Chalumeau N, Le Thi Huong Boutin D, Cacoub P, Cluzel P, Koskas F, Kieffer E, Piette JC, Amoura Z. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore). 2010;89:1-17. doi: 10.1097/MD.0b013e3181cba0a3.
14. de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;79-83. doi: 10.1016/j.jaut.2014.01.012.
15. Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54(Suppl):S141-S147.
16. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56:1000-1009. doi: 10.1002/art.22404.
17. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, Choi SH, Kim YW, Choe YH, Kim DK. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol. 2008;159:14-20.
18. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26(3 Suppl 49):S9-S15.
19. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013;88:822. doi: 10.1016/j.mayocp.2013.04.025.
20. Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005;34:284-292. doi: 10.1080/03009740510026526.
21. Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, Mignot C, Schoindre Y, Chiche L, Hatron PY, Emmerich J, Cacoub P. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012;125:813-819. doi: 10.1161/CIRCULATIONAHA.111.058032.
22. Ohigashi H, Haraguchi G, Konishi M, Tezuka D, Kamiishi T, Ishihara T, Isobe M. Improved prognosis of Takayasu arteritis over the past decade: comprehensive analysis of 106 patients. Circ J. 2012;76:1004-1011.
23. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, SalvaraniC, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318-328. doi: 10.1136/ard.2008.088351.
24. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X; International Network for the Study of Systemic Vasculitides. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-1318. doi: 10.1002/art.10262.
25. Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity. Circulation. 2015;132:1701-1709. doi: 10.1161/CIRCULATIONAHA.114.012547.